not tagged
abbvie
['lymphoma', 'abbvie']
it is an honor to share our late-breaking data during the presidential symposium at #eha2022 from our phase 2 study for our investigational #bispecific antibody in relapsed/refractory large b-cell #lymphoma. hear more during today s presentation: 
We are a leader in harnessing the power of human antibodies and our purpose is to improve the lives of people with cancer | Disclaimer https://t.co/E8NokG2tvL